Association of Gender and Race With Allocation of Advanced Heart Failure Therapies
Crist, Janice D.
Yee, Ryan H.
Knapp, Shannon M.
McEwen, Marylyn M.
Sweitzer, Nancy K.
AffiliationUniv Arizona, Sarver Heart Ctr, Dept Med, Div Cardiol
Univ Arizona, Sarver Heart Ctr, Clin Res Off
Univ Arizona, Coll Nursing
Univ Arizona, Bio5 Inst, Stat Consulting Lab
Univ Arizona, Dept Med
Univ Arizona, Med Sch
Univ Arizona, Dept Psychol
Univ Arizona, Ctr Populat Hlth Sci
MetadataShow full item record
PublisherAMER MEDICAL ASSOC
CitationBreathett K, Yee E, Pool N, et al. Association of Gender and Race With Allocation of Advanced Heart Failure Therapies. JAMA Netw Open. 2020;3(7):e2011044. doi:10.1001/jamanetworkopen.2020.11044
JournalJAMA NETWORK OPEN
Rights© 2020 Breathett K et al.JAMA Network Open. This is an open access article distributed under the terms of the CC-BY License.
Collection InformationThis item from the UA Faculty Publications collection is made available by the University of Arizona with support from the University of Arizona Libraries. If you have questions, please contact us at email@example.com.
AbstractThis qualitative study examines how patient race and gender are associated with clinician recommendations for allocation of advanced heart failure therapies. Importance Racial bias is associated with the allocation of advanced heart failure therapies, heart transplants, and ventricular assist devices. It is unknown whether gender and racial biases are associated with the allocation of advanced therapies among women. Objective To determine whether the intersection of patient gender and race is associated with the decision-making of clinicians during the allocation of advanced heart failure therapies. Design, Setting, and Participants In this qualitative study, 46 US clinicians attending a conference for an international heart transplant organization in April 2019 were interviewed on the allocation of advanced heart failure therapies. Participants were randomized to examine clinical vignettes that varied 1:1 by patient race (African American to white) and 20:3 by gender (women to men) to purposefully target vignettes of women patients to compare with a prior study of vignettes of men patients. Participants were interviewed about their decision-making process using the think-aloud technique and provided supplemental surveys. Interviews were analyzed using grounded theory methodology, and surveys were analyzed with Wilcoxon tests. Exposure Randomization to clinical vignettes. Main Outcomes and Measures Thematic differences in allocation of advanced therapies by patient race and gender. Results Among 46 participants (24 [52%] women, 20 [43%] racial minority), participants were randomized to the vignette of a white woman (20 participants [43%]), an African American woman (20 participants [43%]), a white man (3 participants [7%]), and an African American man (3 participants [7%]). Allocation differences centered on 5 themes. First, clinicians critiqued the appearance of the women more harshly than the men as part of their overall impressions. Second, the African American man was perceived as experiencing more severe illness than individuals from other racial and gender groups. Third, there was more concern regarding appropriateness of prior care of the African American woman compared with the white woman. Fourth, there were greater concerns about adequacy of social support for the women than for the men. Children were perceived as liabilities for women, particularly the African American woman. Family dynamics and finances were perceived to be greater concerns for the African American woman than for individuals in the other vignettes; spouses were deemed inadequate support for women. Last, participants recommended ventricular assist devices over transplantation for all racial and gender groups. Surveys revealed no statistically significant differences in allocation recommendations for African American and white women patients. Conclusions and Relevance This national study of health care professionals randomized to clinical vignettes that varied only by gender and race found evidence of gender and race bias in the decision-making process for offering advanced therapies for heart failure, particularly for African American women patients, who were judged more harshly by appearance and adequacy of social support. There was no associated between patient gender and race and final recommendations for allocation of advanced therapies. However, it is possible that bias may contribute to delayed allocation and ultimately inequity in the allocation of advanced therapies in a clinical setting. Question Is bias against a patient's gender and race associated with the allocation of advanced heart failure therapies? Findings In a qualitative study of 46 health care professionals, there was more bias against women compared with men when evaluating appearance and social support, particularly among African American women. Final recommendations were not different for groups defined by gender or race; all were offered ventricular assist devices rather than transplantation during interviews. Meaning Although gender and race were not associated with allocation of advanced heart failure therapies in this study, there was evidence of bias, which could contribute to delayed and lower allocation of advanced therapies to women.
NoteOpen access journal
VersionFinal published version
Except where otherwise noted, this item's license is described as © 2020 Breathett K et al.JAMA Network Open. This is an open access article distributed under the terms of the CC-BY License.
- Does Race Influence Decision Making for Advanced Heart Failure Therapies?
- Authors: Breathett K, Yee E, Pool N, Hebdon M, Crist JD, Knapp S, Larsen A, Solola S, Luy L, Herrera-Theut K, Zabala L, Stone J, McEwen MM, Calhoun E, Sweitzer NK
- Issue date: 2019 Nov 19
- Racial, gender, and socioeconomic status bias in senior medical student clinical decision-making: a national survey.
- Authors: Williams RL, Romney C, Kano M, Wright R, Skipper B, Getrich CM, Sussman AL, Zyzanski SJ
- Issue date: 2015 Jun
- Assessment of the Inclusion of Racial/Ethnic Minority, Female, and Older Individuals in Vaccine Clinical Trials.
- Authors: Flores LE, Frontera WR, Andrasik MP, Del Rio C, Mondríguez-González A, Price SA, Krantz EM, Pergam SA, Silver JK
- Issue date: 2021 Feb 1
- Unconscious race and social class bias among acute care surgical clinicians and clinical treatment decisions.
- Authors: Haider AH, Schneider EB, Sriram N, Dossick DS, Scott VK, Swoboda SM, Losonczy L, Haut ER, Efron DT, Pronovost PJ, Lipsett PA, Cornwell EE 3rd, MacKenzie EJ, Cooper LA, Freischlag JA
- Issue date: 2015 May
- Temporal Trends in Contemporary Use of Ventricular Assist Devices by Race and Ethnicity.
- Authors: Breathett K, Allen LA, Helmkamp L, Colborn K, Daugherty SL, Blair IV, Jones J, Khazanie P, Mazimba S, McEwen M, Stone J, Calhoun E, Sweitzer NK, Peterson PN
- Issue date: 2018 Aug